<DOC>
	<DOCNO>NCT02582775</DOCNO>
	<brief_summary>This single-institution , phase II study determine event-free survival 1 year post allogeneic transplant serial mesenchymal stem cell ( MSC ) infusion relate donor ( HLA identical , mismatched haploidentical ) match unrelated donor biochemical correction severe epidermolysis bullosa ( EB ) .</brief_summary>
	<brief_title>MT2015-20 : Biochemical Correction Severe EB Allo HSCT Serial Donor MSCs</brief_title>
	<detailed_description />
	<mesh_term>Epidermolysis Bullosa</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Fludarabine phosphate</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Fludarabine</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Diagnosis severe form EB characterize collagen , laminin , integrin , keratin plakin deficiency ( immunofluorescence stain protein specific antibody Western blot mutation analysis ) . An available related donor ( HLA identical , mismatched haploidentical ) match unrelated donor Adequate renal , hepatic , cardiac pulmonary function Evidence HIV infection know HIV positive serology Current active serious infection Diagnosis squamous cell carcinoma Donor EB Pregnancy breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>25 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>